Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Operating Expenses (2016 - 2025)

Neuroone Medical Technologies' Other Operating Expenses history spans 6 years, with the latest figure at $576602.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 3.12% year-over-year to $576602.0; the TTM value through Dec 2025 reached $576602.0, down 70.62%, while the annual FY2024 figure was $1.4 million, N/A changed from the prior year.
  • Other Operating Expenses reached $576602.0 in Q4 2025 per NMTC's latest filing, up from $559130.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.4 million in Q3 2024 to a low of $559130.0 in Q4 2024.